Profil
Thomas V. Hennessey ist im Vorstand von AutoGenomics, Inc. In der Vergangenheit war er Chief Operating & Financial Officer bei AutoImmune, Inc, Chief Operating & Financial Officer bei Boston Scientific Corp, Chief Operating & Financial Officer bei Cambridge Heart, Inc, Chief Financial Officer bei LumeRx, Inc, Chief Operating & Financial Officer bei Photovac, Inc, Chief Operating & Financial Officer bei Behring Diagnostics Business, Chief Operating & Financial Officer bei PHT Corp, Chief Operating & Financial Officer bei Medical Diagnostics, Inc. und Chief Operating & Financial Officer bei SonaMed Corp. Thomas V. Hennessey erwarb ein Diplom und einen Bachelor-Abschluss am Massachusetts Institute of Technology und einen MBA an der Harvard Business School.
Aktive Positionen von Thomas Hennessey
| Unternehmen | Position | Beginn |
|---|---|---|
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas Hennessey
| Unternehmen | Position | Ende |
|---|---|---|
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Finanzdirektor/CFO | 01.01.2003 |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Finanzdirektor/CFO | - |
| CAMBRIDGE HEART, INC. | Finanzdirektor/CFO | - |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Finanzdirektor/CFO | 31.08.2013 |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Finanzdirektor/CFO | - |
Ausbildung von Thomas Hennessey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
AutoImmune, Inc.
AutoImmune, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals orally administered | Health Technology |
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Cambridge Heart, Inc.
Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of products for the non-invasive diagnosis of cardiac disease | Health Technology |
LumeRx, Inc.
LumeRx, Inc. Medical SpecialtiesHealth Technology Develops radiation technology that eliminates bacteria | Health Technology |
AutoGenomics, Inc.
AutoGenomics, Inc. Medical SpecialtiesHealth Technology Designs and develops molecular diagnostics system | Health Technology |
Medical Diagnostics, Inc.
Medical Diagnostics, Inc. Medical/Nursing ServicesHealth Services Mobile MRI services | Health Services |
PHT Corp.
PHT Corp. Packaged SoftwareTechnology Services Designs and develops software applications | Technology Services |
Behring Diagnostics Business
Behring Diagnostics Business Medical SpecialtiesHealth Technology Provides diagnostic services | Health Technology |
Photovac, Inc.
Photovac, Inc. Medical SpecialtiesHealth Technology Portable environmental instruments | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
SonaMed Corp.
SonaMed Corp. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Health Technology |
















